Transradial Access for Heart Procedures Saves Lives in Most Definitive Study Yet Approach beats coronary access through the thigh Aug 29, 2022
Finally, A Foundational Heart Failure Drug That Works Across the Spectrum of EF SGLT2 inhibitor shines in landmark DELIVER trial Aug 27, 2022
ADVOR Backs Add-On Acetazolamide for Cutting Congestion in Decompensated HF Exclusion of patients on SGLT2 inhibitors was a major trial limitation, expert says Aug 27, 2022
Mass Cardiovascular Testing May Add Years for Some Men Mixed results after the DANCAVAS program from Denmark Aug 27, 2022
No Detrimental Impact on Cognition With Entresto for Heart Failure Cost may be reason for underutilization, rather than concerns about cognition, expert noted Aug 26, 2022
No Worsening Cardiac Dysfunction in Long COVID Other harms likely contribute to dyspnea, HF after COVID-19 hospitalization Aug 05, 2022
Heart Disease Will Surge Over the Coming Decades Worsening racial disparities are also projected Aug 01, 2022
Fluid Therapy Showdown in Cardiac Surgery Disfavors Albumin Major adverse events not reduced, and some complications increased Jul 19, 2022
Bye-Bye, 'Life's Simple 7': AHA Redefines Cardiovascular Health by Adding Sleep New metrics and scoring algorithm for heart health in children and adults Jun 29, 2022
Which Advanced HF Patients Are Entresto-Intolerant in the Real World? 1 in 6 dropped out from the LIFE trial because of side effects Jun 27, 2022
Heart Failure Drugs Can Be Unaffordable on Medicare, Study Finds Older adults are subject to cost-sharing and other medication coverage restrictions Jun 21, 2022
TAVR Pacemaker Rate Dips to Single Digits Nationwide, but Outlier Hospitals Remain Do worst-performing sites need more education about best practices? Jun 12, 2022
Fate of Transcatheter Tricuspid Devices: Will it Be Repair or Replacement? Many unanswered questions remain regarding devices for tricuspid regurgitation Jun 11, 2022
TAVR Devices Keep Changing -- Is This Really Helping Patients? Clinical outcomes are headed in the right direction, but better research is needed Jun 10, 2022
Good News for Heart Failure Patients Getting COVID Booster Shots Group saw lower risks for hospitalization, ICU admission, death versus the unvaccinated Jun 09, 2022
TAVR for Aortic Regurgitation Off to a Good Start in the Real World Yet some growing pains remain for the Jenavalve Trilogy May 21, 2022
No-Implant Shunt Eases HF Symptoms in Early Data Quality of life consistently improved across first-in-man studies May 20, 2022
Device Type Matters for Valve-in-Valve TAVR in Small Anatomies Showdown between Sapien and Evolut valves in the LYTEN trial May 20, 2022
TAVR Stays Its Course as 10-Year Durability Data Trickle In Glimpse of longer-term valve degeneration in early TAVR patients May 19, 2022
Cardiac Myosin Inhibitor Gets FDA's Blessing for Obstructive HCM First-in-class mavacamten will be subject to REMS, however Apr 29, 2022
Even With CKD, Patiromer Helped Heart Failure Patients Keep Hyperkalemia at Bay Promising findings from prespecified renal analysis of the DIAMOND trial Apr 09, 2022
Systemic Corticosteroids in Acute HF: Worth Another Look? Some see a potential treatment for patients with more inflammation Apr 08, 2022
TAVR Valve Outlasts Surgical Bioprostheses at 5 Years No longer assume that TAVR bioprostheses are inherently less durable Apr 05, 2022
Patiromer Limits Impact of RAAS Inhibitor-Related Hyperkalemia in HF Patients better able to achieve target dose of mineralocorticoids and angiotensin inhibitors Apr 04, 2022
Flu Vaccine Didn't Stop Vascular Events in Heart Failure Patients But study in lower income countries sees hint of benefit during peak disease season Apr 04, 2022
EHR Pop-Ups Spur Better GDMT Implementation in Heart Failure Alert-based intervention in PROMPT-HF trial said to be low-cost, scalable Apr 03, 2022
Low-Salt Diet Helpful for HF Symptoms, but Not Necessarily for Clinical Events Sodium restriction still holds its ground in SODIUM-HF trial Apr 02, 2022
Obstructive HCM: Will Septal Reduction Zapping Hold Up? More progress on PIMSRA at one Chinese center Mar 30, 2022
ARB-Cancer Link May Come Down to Cumulative Exposure Does a new paper resolve the conflicting safety data on the popular antihypertensives? Mar 02, 2022
A Simple Way to Tell When Asymptomatic Aortic Stenosis Isn't So Benign Could regular NT-proBNP testing be of value to patients with non-severe AS? Feb 16, 2022
ACIP Embraces Spikevax Amid Serious Talk of Changing mRNA Dosing Interval Would longer time between doses do the trick to reduce myocarditis risk? Feb 04, 2022
Adult Congenital Heart Surgery: Go for the Pediatric Specialists? Study suggests worse outcomes at adult centers with expertise in other heart surgeries Jan 31, 2022
Was DOAC to Blame for Patient's LVAD Pump Thrombosis? Direct oral anticoagulant tried after warfarin resistance fell short in this patient with obesity Jan 21, 2022
Death During Sex: Not Just an Old Man Thing But sudden cardiac death remains rare even for sexually active people with heart conditions Jan 12, 2022
ECG Monitoring for Post-TAVR Delayed Conduction Disturbances Put to the Test How long should monitoring last, and in whom? Dec 20, 2021
The Right Ventricle Still Matters in LVAD Patients Right heart failure signaled trouble ahead in the Intermacs registry Nov 29, 2021
Hospitalized Acute HF Patients See Clinical Benefits With Empagliflozin EMPULSE results support early start for the SGLT2 inhibitor, but more data needed, expert says Nov 16, 2021
Peak VO2 Improved After Beta-Blocker Withdrawal in Some HFpEF Patients Beta-blockers may not benefit HFpEF patients with chronotropic incompetence Nov 15, 2021
Delaying Surgery Hurts Patients With Silent Aortic Stenosis Early aortic valve replacement wins in AVATAR trial Nov 13, 2021
More Good News for Empagliflozin in Patients With Heart Failure Slower renal function decline with SGLT-2 inhibitor in EMPEROR-Preserved trial Nov 06, 2021
